Work

Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.2010

Authors: David A. Reardon, John Frederick De Groot, Howard Colman, Justin T Jordan, Mariza Daras, Jennifer Leigh Clarke, Phioanh Leia Nghiemphu, Sarah C. Gaffey, Katherine B. Peters

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, University of California, Los Angeles, Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2696173201

Cites:

Cited by: 40

Related to: 10